DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection

ABSTRACT Hepatitis C virus (HCV) poses a worldwide health problem in that the majority of individuals exposed to HCV become chronically infected and are predisposed for developing significant liver disease. DNA microarray technology provides an opportunity to survey transcription modulation in the context of an infectious disease and is a particularly attractive approach in characterizing HCV-host interactions, since the mechanisms underlying viral persistence and disease progression are not understood and are difficult to study. Here, we describe the changes in liver gene expression during the course of an acute-resolving HCV infection in a chimpanzee. Clearance of viremia in this animal occurred between weeks 6 and 8, while clearance of residual infected hepatocytes did not occur until 14 weeks postinfection. The most notable changes in gene expression occurred in numerous interferon response genes (including all three classical interferon antiviral pathways) that increased dramatically, some as early as day 2 postinfection. The data suggest a biphasic mechanism of viral clearance dependent on both the innate and adaptive immune responses and provide insight into the response of the liver to a hepatotropic viral infection.

[1]  R. Lanford,et al.  Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence. , 2001, The Journal of general virology.

[2]  C. Rice,et al.  Efficient initiation of HCV RNA replication in cell culture. , 2000, Science.

[3]  F. Bazzoni,et al.  The neutrophil as a cellular source of chemokines , 2000, Immunological reviews.

[4]  T. Mizuno,et al.  Eradication of hepatitis C virus 1b by interferon in a health care worker with acute hepatitis following needlestick transmission from a patient with chronic hepatitis C unresponsive to interferon. , 2000, Scandinavian journal of gastroenterology.

[5]  Samir K. Gupta,et al.  A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C , 2000 .

[6]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[7]  L. Laimins,et al.  Microarray Analysis Identifies Interferon-Inducible Genes and Stat-1 as Major Transcriptional Targets of Human Papillomavirus Type 31 , 2000, Journal of Virology.

[8]  Guido Gerken,et al.  Local control of the immune response in the liver , 2000, Immunological reviews.

[9]  D. Metz,et al.  The liver as a site of T‐cell apoptosis: graveyard, or killing field? , 2000, Immunological reviews.

[10]  Roger E Bumgarner,et al.  Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. , 2000, Virology.

[11]  T. Layden Principles of interferon induction therapy. , 1999, The American journal of medicine.

[12]  Scott A. Rifkin,et al.  Microarray analysis of Drosophila development during metamorphosis. , 1999, Science.

[13]  H. Kwon,et al.  Interferon regulatory factors: the next generation. , 1999, Gene.

[14]  F. Chisari,et al.  Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence , 1999, Hepatology.

[15]  H. Bonkovsky,et al.  IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[16]  C. K. Lee,et al.  Gene expression profile of aging and its retardation by caloric restriction. , 1999, Science.

[17]  L. Pelicano,et al.  Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells , 1999, Leukemia.

[18]  D. R. Taylor,et al.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.

[19]  M. Caruso,et al.  Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis. , 1999, Anticancer research.

[20]  T. Taniguchi,et al.  Activation of the Transcription Factor ISGF3 by Interferon-gamma , 1999, Biological chemistry.

[21]  E. Keeffe,et al.  Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference , 1999, Journal of gastroenterology and hepatology.

[22]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[23]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[24]  A. Neumann,et al.  Hepatitis C Virus Kinetics , 1999, Antiviral therapy.

[25]  R. Lanford,et al.  Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees , 1999, Journal of Virology.

[26]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[27]  T. Gingeras,et al.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[29]  H. Rackwitz,et al.  Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases , 1998, Cell and Tissue Research.

[30]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[31]  Michael G. Katze,et al.  Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.

[32]  J. Trapani,et al.  The Human Interferon-inducible Protein, IFI 16, Is a Repressor of Transcription* , 1998, The Journal of Biological Chemistry.

[33]  R. Lanford,et al.  Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical Profiles , 1998, Journal of Virology.

[34]  R. Timpl,et al.  Mac‐2 binding protein is a cell‐adhesive protein of the extracellular matrix which self‐assembles into ring‐like structures and binds β1 integrins, collagens and fibronectin , 1998, The EMBO journal.

[35]  C. Lowenstein,et al.  Midkine Induces Tumor Cell Proliferation and Binds to a High Affinity Signaling Receptor Associated with JAK Tyrosine Kinases* , 1998, The Journal of Biological Chemistry.

[36]  T. Muramatsu,et al.  Midkine, a retinoic acid-inducible heparin-binding cytokine, is a novel regulator of intracellular calcium in human neutrophils. , 1997, Biochemical and biophysical research communications.

[37]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Pagano,et al.  IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency , 1997, Molecular and cellular biology.

[39]  J. Darnell STATs and gene regulation. , 1997, Science.

[40]  K Koike,et al.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.

[41]  S. Wadler,et al.  Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  F. Chisari Cytotoxic T cells and viral hepatitis. , 1997, The Journal of clinical investigation.

[43]  N. Ishimura,et al.  Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. , 1997, Journal of hepatology.

[44]  T. Mak,et al.  The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo , 1996, The Journal of experimental medicine.

[45]  G. Pape,et al.  The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C , 1996, Journal of Molecular Medicine.

[46]  N. Tinari,et al.  Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. , 1996, Journal of hepatology.

[47]  Andrew N. Rowan Guide for the Care and Use of Laboratory Animals , 1996 .

[48]  A. Haas,et al.  Immunoregulatory properties of ISG15, an interferon-induced cytokine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[50]  N. Mechti,et al.  Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression (*) , 1995, The Journal of Biological Chemistry.

[51]  N. Kitamura,et al.  Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. , 1994, European journal of biochemistry.

[52]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[53]  R. Purcell,et al.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Lanford,et al.  The chimpanzee model of hepatitis C virus infections. , 2001, ILAR journal.

[55]  H J Alter,et al.  Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome , 2000, Seminars in liver disease.

[56]  P. Glue,et al.  A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. , 2000, Hepatology.

[57]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[58]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[59]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[60]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[61]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[63]  Hepatitis C: global prevalence. , 1997, Releve epidemiologique hebdomadaire.